Cahaba Pharmaceuticals, LLC
Cahaba Pharmaceuticals, LLC is a private equity fund operated by Brookline Investments, Inc.. The current minimum investment for Cahaba Pharmaceuticals, LLC is $25000. Management owns 16 percent of the fund.
Cahaba Pharmaceuticals, LLC Overview
Fund Type: private equity 
Private Fund ID: 805-5749531683
Fund Manager: Brookline Investments, Inc. (Crd# 109239)
Registered Location: Delaware, United States
Total Assets: $0
Minimum Investment: $25000
Private Funds Managed by Brookline Investments, Inc. (12): Brookline Pope Asset Fund I Llc , Brookline Pope Asset Fund Ii Llc , Brookline Value Investment Fund Llc , Csa Biotechnology Fund Ii Llc, Brookline Ach Investment Fund Llc , Brookline Coronado Investment Fund Llc , Brookline Special Situations Fund Llc , Cahaba Pharmaceuticals Llc , Csa Biotechnology Fund I Llc , Camp One Ventures Fund B Llc , Camp One Ventures Llc , Campone Ventures Fund C
Cahaba Pharmaceuticals, LLC Details
Subadviser: No
Other Investment Advisers: No
Solicited: No
Rely on Reg D Exemption: Yes
Audited: Yes
Master Fund: Yes
Feeder Fund: No
GAAP: Yes
Beneficial Owners: 43
Management Ownership: 16%
Fund of Fund Ownership: 0%
Non-US Ownership: 0%
Auditor(s): Dipiazza Larocca Heeter & Co., Llc
Broker-Dealer(s):
Custodian(s): Iberia Bank
Administrator(s):
Cahaba Pharmaceuticals, LLC Charts and Graphs
Total AUM: $0
Rank: 29844 out of 30967 registered private funds
Minimum Investment: $25000
Rank: 23164 out of 30967 registered private funds
Management Ownership: 16%
Rank: 6822 out of 30967 registered private funds
Go back to private fund search
